Angiotensin receptor-neprilysin inhibition by sacubitril/valsartan attenuates doxorubicin-induced cardiotoxicity in a pretreatment mice model by interfering with oxidative stress, inflammation, and Caspase 3 apoptotic pathway
Enregistré dans:
| Auteurs principaux: | Ferhat Dindaş, Hüseyin Güngör, Mehmet Ekici, Pınar Akokay, Füsun Erhan, Mustafa Doğduş, Mehmet Birhan Yılmaz |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
KARE Publishing
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/a011776f59644852a2964dfe06d69ce9 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Sacubitril/valsartan in real-life clinical practice
par: Yüksel Çavuşoğlu
Publié: (2021) -
Sacubitril/valsartan alleviates myocardial fibrosis in diabetic cardiomyopathy rats
par: Jiao Ai, et autres
Publié: (2021) -
Renal protective effect of sacubitril/valsartan in patients with heart failure
par: Hui-Ling Hsieh, et autres
Publié: (2021) -
Cardiovascular Outcomes with Sacubitril-Valsartan in Heart Failure: Emerging Clinical Data
par: Cuthbert JJ, et autres
Publié: (2020) -
Cardioprotective effects of early intervention with sacubitril/valsartan on pressure overloaded rat hearts
par: Xiaofei Li, et autres
Publié: (2021)